Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

TGTXTGTX
Showing 8 of 31 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in TG Therapeutics, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds 1.3M shares of TGTX (TG Therapeutics, Inc.), worth $72.1M as of 2026-Q2. The position was increased (+1.4% shares). TGTX represents 0.0% of CHARLES SCHWAB INVESTMENT MANAGEMENT INC's portfolio.

Current Value

$72.1M

Current Shares

1.3M

Total Value Change

+$44.4M

Total Shares Change

+128,494

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.3M
+1.4%
$72.1M0.0%$54.94
30
2026-Q1
Decreased
1.3M
-1.3%
$43M0.0%$28.88
0
2025-Q4
Increased
1.3M
+0.1%
$39.1M0.0%$29.75
29
2025-Q3
Decreased
1.3M
-0.5%
$47.3M0.0%$36.83
0
2025-Q2
Increased
1.3M
+4.2%
$47.4M0.0%$36.72
31
2025-Q1
Decreased
1.3M
-0.5%
$49.8M0.0%$39.86
0
2024-Q4
Increased
1.3M
+7.2%
$38.2M0.0%$31.44
31
2024-Q3
Increased
1.2M
+0.7%
$27.7M0.0%$23.83
29

Other major holders of TGTX: BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used